Nguyen D, Jabbour E, Kantarjian HM, Macaron W, Jain N, Nasnas C, Kebriaei P, Shpall EJ, Khouri I, Haddad F, Karrar O, Maroun M, Garris R, Ravandi F, Short NJ. Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia. Haematologica; https://doi.org/10.3324/haematol.2025.289318 [Early view].